Our Webinars

Our Webinars

The Increasing Role of Pharmacometrics in Drug Development

The Increasing Role of Pharmacometrics in Drug Development

Date: Monday, September 30, 2019
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 60 minutes

REGISTER

The cost of a new drug from discovery to launch is approaching $3B with the underlying time for development reaching up to 12 years. Given the costly and lengthy process, scientific and regulatory leaders in the pharmaceutical industry need to leverage all available tools to get drugs approved quickly and efficiently, bringing safe and efficacious medications for human needs. In recent years, pharmacometrics has emerged as an invaluable modeling and simulation tool that helps to de-risk and accelerate the drug development process. It facilitates the integration of preclinical/clinical development data and provides a scientifically based framework for designing a rationale dosage regimen and treatment optimization. There are several pharmacometrics techniques that can be elicited at various stages in the drug development pipeline to help make the approval process more efficient and get the most efficacious doses with increased safety for all patients, including special populations.

This webinar will provide an overview of different pharmacometrics tools and techniques, including guidance as to when they can be applied and key considerations about why this may be necessary for most of your studies.

Presenters:

  • Felix Boakye-Agyeman, MD PhD, Director, Pharmacokinetics, Synteract
  • Rakesh Gollen, PhD, Director, Pharmacokinetics, Synteract


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience
x

Synteract Rare and Orphan Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP Rare and Orphan Diseases

Contact us to find out more about our Rare and Orphan Diseases expertise and experience
x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required